Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
3.930
+0.200 (5.36%)
Aug 10, 2026, 11:07 AM EDT - Market open
Pyxis Oncology Revenue
Pyxis Oncology had revenue of $13.86M in the twelve months ending March 31, 2026. In the year 2025, Pyxis Oncology had annual revenue of $13.86M, down -14.17%.
Revenue (ttm)
$13.86M
Revenue Growth
-14.17%
P/S Ratio
17.28
Revenue / Employee
$247,464
Employees
56
Market Cap
248.99M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.86M | -2.29M | -14.17% |
| Dec 31, 2024 | 16.15M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Niagen Bioscience | 129.08M |
| Compugen | 74.00M |
| Invivyd | 55.87M |
| Orchestra BioMed Holdings | 32.72M |
| AC Immune | 21.67M |
| Keros Therapeutics | 15.01M |
| Capricor Therapeutics | 11.13M |
| Entrada Therapeutics | 4.69M |
PYXS News
- 7 days ago - Pyxis Oncology initiated with an Overweight at Wells Fargo - TheFly
- 5 weeks ago - Pyxis Oncology announces up to $114M private placement - TheFly
- 5 weeks ago - Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones - GlobeNewsWire
- 2 months ago - Pyxis Oncology Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Pyxis Oncology Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 2 months ago - Pyxis Oncology Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 3 months ago - Pyxis Oncologyreports Q1 EPS (37c), consensus (35c) - TheFly
- 3 months ago - Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones - GlobeNewsWire